美國的社會處方：新興學習與機遇

Social prescribing in the USA: emerging learning and opportunities

——《柳葉刀 / 公共衛生》2025年第10卷第6期——

Volume 10, Issue 6, 2025

【摘要】慢性病在全球的流行和高昂的醫療費用是複雜的挑戰，促使各國致力於解決健康的社會決定因素以及隨之而來的社會需求。這些挑戰需要創新的醫療保健實踐，將疾病預防、治療和管理與有益健康的舉措相結合，以促進人口健康。許多國家已將社會處方視為一種有前景的方法。社會處方將人們與其社區內的非臨床支持和服務聯繫起來。雖然社會處方在政府資助的國家更為普遍，但在本觀點中，我們分享了美國的經驗教訓。我們認為，鑑於美國國家及其衛生系統的異質性，美國的社會處方是獨一無二的，並且這方面影響着項目活動、目標人群和模式。這些案例提供了寶貴的經驗教訓，說明了在不同環境下（包括私有化醫療保健系統）實施社會處方的障礙和推動因素。最後，我們呼籲美國利益相關者認識到社會處方可能為公共衛生帶來的益處，並採取行動支持其發展。我們也邀請其他國家的利益相關者借鑑美國的經驗，並探討如何在本國成功實施社會處方。

[Summary] The global prevalence of chronic diseases and high costs of health care are complex challenges that are driving countries to focus on addressing the social determinants of health and downstream social needs. These challenges require innovative health-care practices that integrate disease prevention, treatment, and management with salutogenic initiatives to promote population health. Many countries have turned to social prescribing as a promising approach. Social prescribing connects people with non-clinical support and services within their communities. While social prescribing has more commonly been adopted in countries with government-funded national health services, in this Viewpoint, we share learning from examples in the USA. We argue that social prescribing in the USA is unique given the heterogeneity of the country and its health systems, and that this aspect influences programme activities, target-populations, and models. These examples offer valuable lessons about the barriers and enablers to implementing social prescribing in different contexts, including privatised health-care systems. Ultimately, we call upon US stakeholders to recognise the benefits that social prescribing could bring to public health and take action to support its development. We also invite stakeholders from other countries to consider learnings from the USA and how social prescribing can be successfully implemented in their contexts.

論文原文：Rachel Marshall, Alexandra Bradbury, Nicole Morgan, Katrina Pineda,  Daniel Hayes, Alexandra Burton, et al. (2025). Social prescribing in the USA: emerging learning and opportunities. The Lancet / Public Health. Volume 10, Issue 6, Pages 531-536. June 2025.

https://doi.org/10.1016/S2468-2667(25)00066-0

（需要英文原文的朋友，請聯繫微信：millerdeng95或iacmsp）